Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 109 matching records.
109 results — page 1 of 5
- Level DNarrative ReviewEurope PMC
From the energy factory to the intercellular communication medium: the emerging role of intercellular mitochondrial transfer and mitochondrial transplantation therapy in diabetes and diabetic complications
Narrative Review on Type 2 Diabetes, published in J Transl Med (2026) — summary generated from the PubMed abstract.
- 2026
J Transl Med - Level DNarrative ReviewEurope PMC
What Is the Current State of Stem Cell Therapy in Diabetes?
Narrative Review on Systemic / IV, published in Cells (2026) — summary generated from the PubMed abstract.
- 2026
Cells - Level CProspective StudyPubMed
Type 2 Diabetes-Induced Molecular and Functional Impairment of Adipose Tissue-Derived Mesenchymal Stromal Cells (ASCs) and Interferon Gamma Priming for Enhanced Diabetic ASC-Based Therapy.
Prospective Study on Type 2 Diabetes, Chronic Inflammation, Immune Modulation, published in Stem Cell Rev Rep (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Rev Rep - Level DNarrative ReviewEurope PMC
Determinants of Colorectal Cancer: An Integrative Immunometabolic Framework Linking Biomarkers, Therapy, and the Diet-Microbiota Axis
Narrative Review on Type 2 Diabetes, published in Cells (2026) — summary generated from the PubMed abstract.
- 2026
Cells - Level DNarrative ReviewEurope PMC
Targeting ferroptosis: opportunities and challenges of mesenchymal stem cell therapy for type 1 diabetes mellitus
Narrative Review on Type 1 Diabetes, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther3 citations - Level AMeta-analysisPubMed
A meta-analysis on application and prospect of cell therapy in the treatment of diabetes mellitus.
Meta-analysis on Diabetic Foot, Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level DAnimal StudyPubMed
Photobiomodulation therapy: a promising treatment for insulin resistance in type 2 diabetes.
Animal Study on Type 2 Diabetes, published in In Vitro Cell Dev Biol Anim (2025) — summary generated from the PubMed abstract.
- 2025
In Vitro Cell Dev Biol Anim - Level DNarrative ReviewPubMed
Application of human iPSC-derived white, beige, and brown adipocytes for metabolic disease modeling and transplantation therapy.
Narrative Review on Type 2 Diabetes, published in Cell Transplant (2025) — summary generated from the PubMed abstract.
- 2025
Cell Transplant4 citations - Level CProspective StudyPubMed
Incretin-based approaches for type 2 diabetes therapy: effects on circulating cytokines and adipocyte's secretome.
Prospective Study with a reported sample of 17 on Type 2 Diabetes, Chronic Inflammation, published in BMC Endocr Disord (2025) — summary generated from the PubMed abstract.
- 2025
- n = 17
BMC Endocr Disord1 citations - Level BClinical TrialEurope PMC
Stem cell therapy for diabetes: Advances, prospects, and challenges
Clinical Trial on Type 2 Diabetes, published in World J Diabetes (2025) — summary generated from the PubMed abstract.
- 2025
World J Diabetes6 citations - Level BClinical TrialPubMed
Current status and advances in adipose-derived stem cells therapy for diabetes mellitus erectile dysfunction.
Clinical Trial on Systemic / IV, published in Front Med (Lausanne) (2025) — summary generated from the PubMed abstract.
- 2025
Front Med (Lausanne) - Level DAnimal StudyPubMed
StemBell Therapy Does Not Significantly Affect Atherosclerotic Plaque Characteristics in a Streptozotocin-Induced Diabetes Mellitus Mouse Model.
Animal Study with a reported sample of 18 on Chronic Inflammation, published in Biology (Basel) (2025) — summary generated from the PubMed abstract.
- 2025
- n = 18
Biology (Basel) - Level BClinical TrialPubMed
Mesenchymal stem cell therapy for type 2 diabetes: mechanisms, clinical evidence, and future directions.
Clinical Trial on Type 2 Diabetes, Chronic Kidney Disease, Chronic Wound, Immune Modulation, published in Mol Biol Rep (2025) — summary generated from the PubMed abstract.
- 2025
Mol Biol Rep - Level DNarrative ReviewPubMed
Advances in Stem Cell Therapy for Diabetic Foot Ulcers.
Narrative Review on Diabetic Foot, Chronic Inflammation, published in Diabetes Metab Syndr Obes (2025) — summary generated from the PubMed abstract.
- 2025
Diabetes Metab Syndr Obes1 citations - Level DAnimal StudyPubMed
Optimizing adipose-derived stem cell therapy for diabetic foot ulcers.
Animal Study on Diabetic Foot, Chronic Wound, Chronic Inflammation, Immune Modulation, published in World J Diabetes (2025) — summary generated from the PubMed abstract.
- 2025
World J Diabetes - Level DNarrative ReviewEurope PMC
Mesenchymal stem cell-derived extracellular vesicles for disease therapy by regulating ferroptosis: focus on diabetes mellitus and diabetic complications
Narrative Review on Systemic / IV, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther2 citations - Level DNarrative ReviewEurope PMC
Review of Hyperbaric Oxygen Therapy as an Adjunctive Intervention for Metabolic Disorders
Narrative Review on Type 2 Diabetes, Chronic Wound, published in Antioxidants (Basel) (2025) — summary generated from the PubMed abstract.
- 2025
Antioxidants (Basel) - Level DNarrative ReviewEurope PMC
Exploring Mesenchymal Stromal Cells as a Potential Therapy for Comorbid Osteoarthritis and Type 2 Diabetes Mellitus
Narrative Review on Osteoarthritis, Type 2 Diabetes, published in Stem Cells Int (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cells Int1 citations - Level BClinical TrialEurope PMC
Current status of stem cell therapy for type 1 diabetes: a critique and a prospective consideration
Clinical Trial on Type 1 Diabetes, Type 2 Diabetes, Immune Modulation, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Res Ther25 citations - Level CProspective StudyPubMed
The cross talk between type II diabetic microenvironment and the regenerative capacities of human adipose tissue-derived pericytes: a promising cell therapy.
Prospective Study on Type 2 Diabetes, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Res Ther - Level CProspective StudyPubMed
Semaglutide 6-months therapy of type 2 diabetes mellitus restores adipose progenitors potential to develop metabolically active adipocytes.
Prospective Study on Type 2 Diabetes, published in Eur J Pharmacol (2024) — summary generated from the PubMed abstract.
- 2024
Eur J Pharmacol13 citations - Level DAnimal StudyPubMed
Silencing of forkhead box protein O-1 (FOXO-1) enhances insulin-producing cell generation from adipose mesenchymal stem cells for diabetes therapy.
Animal Study on Systemic / IV, published in Life Sci (2024) — summary generated from the PubMed abstract.
- 2024
Life Sci - Level DNarrative ReviewEurope PMC
The Immunomodulatory effect of exosomes in diabetes: a novel and attractive therapeutic tool in diabetes therapy
Narrative Review on Immune Modulation, published in Front Immunol (2024) — summary generated from the PubMed abstract.
- 2024
Front Immunol6 citations - Level DNarrative ReviewEurope PMC
Immunoprotection Strategies in β-Cell Replacement Therapy: A Closer Look at Porcine Islet Xenotransplantation
Narrative Review on Type 1 Diabetes, Scar, Immune Modulation, Autoimmune Research, published in Adv Sci (Weinh) (2024) — summary generated from the PubMed abstract.
- 2024
Adv Sci (Weinh)15 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406